Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirements

The only amendment related to post-market regulation is the Minister’s new (continued) authority to impose terms and conditions for a designated COVID-19 drug (C.01.014.21).

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-07-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data